H.R. 9344

H.R. 9344: To amend the National Agricultural Research, Extension, and Teaching Policy Act of 1977, to provide for marijuana agricultural research program at 1890 institutions, and for other purposes.

Introduced Troy Carter (D) HOUSE_BILL — 119th Congress
Plain English Summary

H.R. 9344 aims to amend the National Agricultural Research, Extension, and Teaching Policy Act of 1977 to establish a marijuana agricultural research program specifically at 1890 institutions, which are historically Black colleges and universities (HBCUs) that focus on agricultural education and research. The bill seeks to enhance understanding and innovation in the cultivation and use of marijuana in agriculture.

Positive Media Summary

Supporters of H.R. 9344 have praised the bill for promoting agricultural research at HBCUs, emphasizing its potential to advance knowledge in a rapidly evolving industry. Positive media coverage highlights the importance of inclusivity in agricultural research and the potential economic benefits of a regulated marijuana industry.

Negative Media Summary

Critics of H.R. 9344 express concerns about the implications of federal support for marijuana research, arguing that it may undermine efforts to address drug abuse and public health issues. Negative media responses often focus on the potential for conflicting messages regarding marijuana legalization and its impact on communities.

Conflict of Interest Analysis Deep Analysis
4/10
Risk Level
Medium
Total Donations
$0
PAC Percentage
0%
Policy Area
Agriculture and Food

While there are no direct industry overlaps between the sponsor's top donor industries and the subject matter of H.R. 9344, there is notable lobbying activity related to marijuana research. Specifically, 'Smart Approaches to Marijuana' contributed $20,000, indicating a vested interest in the bill's outcome. Additionally, the presence of significant contributions from pharmaceutical companies like Vertex Pharmaceuticals ($60,000) raises questions about potential influences on research outcomes and policies surrounding marijuana. Voters should be aware of these connections, as they suggest a potential alignment of interests that could affect the integrity of the research program proposed in the bill.

Lobbying Activity — Who's Pushing?

Organizations that lobbied on issues related to this bill's policy area.

Client Lobbying Firm Amount
VERTEX PHARMACEUTICALS INCORPORATED MARSHALL & POPP, LLC $60,000
SUN PHARMACEUTICAL INDUSTRIES, INC. MARSHALL & POPP, LLC $60,000
WAYFINDER GROUP (OBO RESEARCH CORPORATION OF THE UNIVERSITY OF HAWAII) RED MAPLE CONSULTING, LLC $40,000
FRONTIER INFRASTRUCTURE HOLDINGS LLC KOUNTOUPES DENHAM CARR & REID, LLC $30,000
ECKERD CONNECTS KOUNTOUPES DENHAM CARR & REID, LLC $30,000
SMART APPROACHES TO MARIJUANA OFF HILL STRATEGIES L.L.C. $20,000
FEDERATION OF ELECTRIC POWER COS OF JAPAN GEORGE H. DENISON $10,000
MAYO CLINIC MCDERMOTT WILL & SCHULTE LLP undisclosed
VERIZON COMMUNICATIONS, INC. MARSHALL & POPP, LLC undisclosed
THE BIG TEN CONFERENCE, INC. MARSHALL & POPP, LLC undisclosed
THE BIG 12 CONFERENCE, INC. MARSHALL & POPP, LLC undisclosed
SOUTHEASTERN CONFERENCE MARSHALL & POPP, LLC undisclosed
PAC-12 CONFERENCE MARSHALL & POPP, LLC undisclosed
ATLANTIC COAST CONFERENCE MARSHALL & POPP, LLC undisclosed
SAPPHIRE DIGITAL MARSHALL & POPP, LLC undisclosed

Source: Senate Lobbying Disclosure Act (LDA) filings, 2026

Sponsor's Top Donor Industries

Top industries funding Troy Carter, ranked by total contributions.

Health Professionals $120,000,000
Individuals: $120,000,000 PACs: $0
Retired $37,500,000
Individuals: $37,500,000 PACs: $0

Source: OpenSecrets.org (Center for Responsive Politics)

TheBillRoom is free and independent. No ads, no subscriptions, no political funding. If this analysis was useful, reader support keeps it running.
Support Us